Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00712829 | Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents | completed | Phase 1 | 12 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00992745 | A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer | completed | Phase 1 | 24 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 12, 2011 |
| clinicaltrials |
| NCT00129025 | Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 35 | Alberta Health servicesOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT01440855 | Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting | completed | N/A | 340 | Fox Chase Cancer CenterOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT00335491 | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | completed | N/A | 49 | University of UtahOTHER | 1 | Sep 30, 2011 | clinicaltrials |
| NCT00380055 | Reducing Cancer Disparities for American Indians in the Rural Intermountain West | completed | N/A | 1,800 | University of UtahOTHER | 1 | Sep 21, 2011 | clinicaltrials |
| NCT00925418 | Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer(CRYO1) | completed | Phase 3 | 168 | Institut Paoli-CalmettesOTHER | 1 | Sep 14, 2011 | clinicaltrials |
| NCT01428869 | Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer | completed | — | 8,231 | University Health Network, TorontoOTHER | 1 | Sep 9, 2011 | clinicaltrials |
| NCT00336934 | Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer | completed | N/A | 183 | Roll International CorporationINDUSTRY | 0 | Aug 15, 2011 | clinicaltrials |
| NCT00176579 | Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer | completed | — | 27 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Aug 12, 2011 | clinicaltrials |
| NCT00003038 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00626431 | A Study of Leuprolide to Treat Prostate Cancer | completed | Phase 3 | 310 | AbbottINDUSTRY | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00286793 | Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC | completed | Phase 1 / Phase 2 | 76 | Ascenta TherapeuticsINDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00148772 | Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy | completed | Phase 2 | 29 | Endeavor HealthOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00050596 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00134654 | Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer | completed | Phase 2 | 48 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 16, 2011 | clinicaltrials |
| NCT00268593 | Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer | completed | Phase 2 | 48 | Progen PharmaceuticalsINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00069888 | A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy | completed | Phase 2 | 83 | SanofiINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00379782 | Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project | completed | N/A | 628 | Queen's Medical CenterOTHER | 1 | May 30, 2011 | clinicaltrials |
| NCT00117949 | Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 | completed | Phase 2 | 82 | Ferring PharmaceuticalsINDUSTRY | 1 | May 23, 2011 | clinicaltrials |
| NCT00405210 | Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer | completed | Phase 1 | 38 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | May 23, 2011 | clinicaltrials |
| NCT00270166 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | completed | Phase 3 | 201 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | May 18, 2011 | clinicaltrials |
| NCT00554086 | Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.(CHICS) | completed | Phase 2 | 65 | Canadian Urology Research ConsortiumOTHER | 1 | May 16, 2011 | clinicaltrials |
| NCT00627354 | Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 2 | 90 | Groupe D'Etude des Tumeurs Uro-GenitalesOTHER | 1 | May 16, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00244309 | Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer | completed | Phase 3 | 348 | Case Comprehensive Cancer CenterOTHER | 1 | May 4, 2011 | clinicaltrials |
| NCT00193271 | Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer | completed | Phase 2 | 30 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT00782366 | Predictive Genetic Risk Assessment Trial(PGT) | completed | — | 26 | Mayo ClinicOTHER | 1 | Apr 27, 2011 | clinicaltrials |
| NCT00921193 | Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer | completed | N/A | 20 | Navotek Medical, Ltd.INDUSTRY | 2 | Mar 30, 2011 | clinicaltrials |
| NCT00468286 | Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy | completed | Phase 2 | 133 | Ferring PharmaceuticalsINDUSTRY | 5 | Mar 23, 2011 | clinicaltrials |
| NCT00446901 | Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression(SePros) | completed | N/A | 60 | Wageningen UniversityOTHER | 1 | Mar 14, 2011 | clinicaltrials |
| NCT00716794 | A Phase I/II Study of HE3235 in Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 64 | Harbor TherapeuticsINDUSTRY | 1 | Mar 9, 2011 | clinicaltrials |
| NCT00054522 | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy | completed | Phase 2 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00859768 | The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | completed | N/A | 568 | Netherlands Open UniversityOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT00900835 | Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | completed | N/A | 470 | City of Hope Medical CenterOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00003115 | Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy | completed | Phase 3 | 40 | Roswell Park Cancer InstituteOTHER | 1 | Feb 23, 2011 | clinicaltrials |
| NCT00032058 | Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | completed | N/A | — | American College of Radiology Imaging NetworkNETWORK | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00046943 | Atrasentan in Treating Patients With Prostate Cancer | completed | Phase 3 | — | AbbottINDUSTRY | 1 | Feb 21, 2011 | clinicaltrials |
| NCT00834392 | Exercise in Men With Prostate Cancer | completed | N/A | 30 | University of ManitobaOTHER | 1 | Feb 1, 2011 | clinicaltrials |
| NCT00856102 | Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy | completed | N/A | 30 | University of ManitobaOTHER | 1 | Feb 1, 2011 | clinicaltrials |
| NCT00233610 | Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer | completed | Phase 3 | 180 | AstraZenecaINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT00319787 | Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer | completed | Phase 2 | 102 | AstraZenecaINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00326586 | A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer | completed | Phase 1 | 54 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00644488 | A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer | completed | Phase 1 | 7 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00637871 | Casodex - Nolvadex Combination | completed | Phase 2 | — | AstraZenecaINDUSTRY | 0 | Jan 24, 2011 | clinicaltrials |
| NCT00502164 | Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer(AZD2171IL/0003) | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00268892 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 278 | Ferring PharmaceuticalsINDUSTRY | 10 | Dec 24, 2010 | clinicaltrials |
| NCT00252941 | Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma | completed | Phase 1 / Phase 2 | 20 | The Cleveland ClinicOTHER | 1 | Dec 21, 2010 | clinicaltrials |
| NCT00264420 | Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation | completed | Phase 1 | 4 | The Cleveland ClinicOTHER | 0 | Dec 21, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Oct 12, 2011source: clinicaltrials